Ashley L Wilson

8PUBLICATIONS
79CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 18, 2026
The first-in-human ENCIT01 trial comparing second- versus third-generation L1CAM-specific CAR T cells in patients with primary refractory or relapsed neuroblastoma.

|Jan 08, 2025
Intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trial.

Nicholas A Vitanza, Rebecca Ronsley, Michelle Choe

|Sep 10, 2024
STRIvE-02: A First-in-Human Phase I Study of Systemically Administered B7-H3 Chimeric Antigen Receptor T Cells for Patients With Relapsed/Refractory Solid Tumors.

Navin Pinto, Catherine M Albert, Mallory R Taylor

|Mar 05, 2024
Differential protein-protein interactions underlie signaling mediated by the TCR and a 4-1BB domain-containing CAR.

Samuel A Ritmeester-Loy, Isabella H Draper, Eric C Bueter

|Jan 06, 2023
A stem cell epigenome is associated with primary nonresponse to CD19 CAR T cells in pediatric acute lymphoblastic leukemia.

Katherine E Masih, Rebecca A Gardner, Hsien-Chao Chou

|Oct 19, 2022
Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety.

Nicholas A Vitanza, Ashley L Wilson, Wenjun Huang

Pageof 2

Frequent Collaborators

5 joint publications

Julie R Park

5 joint publications

Rebecca A Gardner

5 joint publications

Wenjun Huang

4 joint publications

Michael C Jensen